The Chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice

Gastroenterology

Volumn 140, Issue 5, 2011, Pages

  Wermers, Joshua D ^a   McNamee, Eoin N ^a   Wurbel, Marc André ^c   Jedlicka, Paul ^b   Riveranieves, Jesús ^a,d  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD; Immune System; Inflammation; Regulatory T Cells

Indexed keywords

CD103 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; CHEMOKINE LIGAND 25; CHEMOKINE RECEPTOR CCR9; FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR P3; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHRONIC INFLAMMATION; CROHN DISEASE; EFFECTOR CELL; ILEITIS; IN VITRO STUDY; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

EID: 79955396012     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.01.044     Document Type: Article

References (36)

1. W. Strober, B.R. Ludviksson, and I.J. Fuss The pathogenesis of mucosal inflammation in murine models of inflammatory bowel disease and Crohn disease Ann Intern Med 128 1998 848 856 (Pubitemid 28267719)
2. S.R. Targan, B.G. Feagan, and R.N. Fedorak Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial Gastroenterology 132 2007 1672 1683 (Pubitemid 46695722)
3. E. Butcher, M. Williams, and K. Youngman Lymphocyte trafficking and regional immunity Adv Immunol 72 1999 209
4. M.A. Wurbel, M. Malissen, and D. Guy-Grand Impaired accumulation of antigen-specific CD8 lymphocytes in chemokine CCL25-deficient intestinal epithelium and lamina propria J Immunol 178 2007 7598 7606 (Pubitemid 46898029)
5. K.A. Papadakis, J. Prehn, and S.T. Moreno CCR9-positive lymphocytes and thymus-expressed chemokine distinguish small bowel from colonic Crohn's disease Gastroenterology 121 2001 246 254 (Pubitemid 32729371)
6. B. Eksteen, A.J. Grant, and A. Miles Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis J Exp Med 200 2004 1511 1517 (Pubitemid 39657298)
7. K.A. Papadakis, C. Landers, and J. Prehn CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile J Immunol 171 2003 159 165 (Pubitemid 36745284)
8. K. Satish, J. Daniel, and B. Pirow 392 PROTECT-1 study demonstrated efficacy of the intestine-specific chemokine receptor antagonist CCX282-B (Traficet-EN) in treatment of patients with moderate to severe Crohn's disease Gastroenterology 136 2009 A-65
9. M. Apostolaki, M. Manoloukos, and M. Roulis Role of beta7 integrin and the chemokine/chemokine receptor pair CCL25/CCR9 in modeled TNF-dependent Crohn's disease Gastroenterology 134 2008 2025 2035 (Pubitemid 351790742)
10. D. Kontoyiannis, M. Pasparakis, and T.T. Pizarro Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies Immunity 10 1999 387 398 (Pubitemid 29165293)
11. C.B. Collins, J. Ho, and T.E. Wilson CD44 deficiency attenuates chronic murine ileitis Gastroenterology 135 2008 1993 2002
12. S. Uehara, A. Grinberg, and J.M. Farber A role for CCR9 in T lymphocyte development and migration J Immunol 168 2002 2811 2819 (Pubitemid 34211660)
13. R.C. Burns, J. Rivera-Nieves, and C.A. Moskaluk Antibody blockade of ICAM-1 and VCAM-1 ameliorates inflammation in the SAMP-1/Yit adoptive transfer model of Crohn's disease in mice Gastroenterology 121 2001 1428 1436 (Pubitemid 33140460)
14. J. Rivera-Nieves, J. Ho, and G. Bamias Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis Gastroenterology 131 2006 1518 1529 (Pubitemid 44708936)
15. H. Stenstad, M. Svensson, and H. Cucak Differential homing mechanisms regulate regionalized effector CD8alphabeta+ T cell accumulation within the small intestine Proc Natl Acad Sci U S A 104 2007 10122 10127 (Pubitemid 47175273)
16. E.J. Kunkel, J.J. Campbell, and G. Haraldsen Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity J Exp Med 192 2000 761 768
17. D. Kontoyiannis, G. Boulougouris, and M. Manoloukos Genetic dissection of the cellular pathways and signaling mechanisms in modeled tumor necrosis factor-induced Crohn's-like inflammatory bowel disease J Exp Med 196 2002 1563 1574 (Pubitemid 36026468)
18. J. Ho, C.C. Kurtz, and M. Naganuma A CD8+/CD103high T cell subset regulates TNF-mediated chronic murine ileitis J Immunol 180 2008 2573 2580
19. M. Iwata, A. Hirakiyama, and Y. Eshima Retinoic acid imprints gut-homing specificity on T cells Immunity 21 2004 527 538 (Pubitemid 39370508)
20. J.L. Coombes, K.R. Siddiqui, and C.V. Arancibia-Carcamo A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism J Exp Med 204 2007 1757 1764 (Pubitemid 47236314)
21. G.A. Hadley, S.T. Bartlett, and C.S. Via The epithelial cell-specific integrin, CD103 (alpha E integrin), defines a novel subset of alloreactive CD8+ CTL J Immunol 159 1997 3748 3756 (Pubitemid 127469629)
22. M. Svensson, B. Johansson-Lindbom, and F. Zapata Retinoic acid receptor signaling levels and antigen dose regulate gut homing receptor expression on CD8+ T cells Mucosal Immunol 1 2008 38 48
23. M.R. Britschgi, A. Link, and T.K. Lissandrin Dynamic modulation of CCR7 expression and function on naive T lymphocytes in vivo J Immunol 181 2008 7681 7688
24. E.S. Baekkevold, T. Yamanaka, and R.T. Palframan The CCR7 ligand elc (CCL19) is transcytosed in high endothelial venules and mediates T cell recruitment J Exp Med 193 2001 1105 1112
25. N. Hosoe, S. Miura, and C. Watanabe Demonstration of functional role of TECK/CCL25 in T lymphocyte-endothelium interaction in inflamed and uninflamed intestinal mucosa Am J Physiol Gastrointest Liver Physiol 286 2004 G458 G466
26. A. Mantovani, R. Bonecchi, and M. Locati Tuning inflammation and immunity by chemokine sequestration: decoys and more Nat Rev Immunol 6 2006 907 918 (Pubitemid 44851733)
27. N. Feng, M.C. Jaimes, and N.H. Lazarus Redundant role of chemokines CCL25/TECK and CCL28/MEC in IgA+ plasmablast recruitment to the intestinal lamina propria after rotavirus infection J Immunol 176 2006 5749 5759
28. A. Ericsson, K. Kotarsky, and M. Svensson Functional characterization of the CCL25 promoter in small intestinal epithelial cells suggests a regulatory role for caudal-related homeobox (Cdx) transcription factors J Immunol 176 2006 3642 3651 (Pubitemid 43372208)
29. Z.E.L. Wei, T. Baumgart, and W. Rubas CC chemokine receptor 9 (CCR9) antagonist ameliorates experimental ileitis and colitis Gastroenterology 128 2005 A204 A205
30. W. Strober, I.J. Fuss, and R.S. Blumberg The immunology of mucosal models of inflammation Annu Rev Immunol 20 2002 495 549 (Pubitemid 34293433)
31. J.D. Fontenot, M.A. Gavin, and A.Y. Rudensky Foxp3 programs the development and function of CD4+CD25+ regulatory T cells Nat Immunol 4 2003 330 336 (Pubitemid 36432314)
32. Q.T. Yu, M. Saruta, and A. Avanesyan Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis Inflamm Bowel Dis 13 2007 191 199 (Pubitemid 46806228)
33. H.H. Uhlig, J. Coombes, and C. Mottet Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis J Immunol 177 2006 5852 5860
34. Z. Guo, M.H. Jang, and K. Otani CD4+CD25+ regulatory T cells in the small intestinal lamina propria show an effector/memory phenotype Int Immunol 20 2008 307 315 (Pubitemid 351321238)
35. K. Nakamura, A. Kitani, and I. Fuss TGF-beta 1 plays an important role in the mechanism of CD4+CD25+ regulatory T cell activity in both humans and mice J Immunol 172 2004 834 842 (Pubitemid 38113739)
36. M.J. Walters, Y. Wang, and N. Lai Characterization of CCX282-B, an orally bioavailable antagonist of the CCR9 chemokine receptor, for treatment of inflammatory bowel disease J Pharmacol Exp Ther 335 2010 61 69